Showing results (121-130 of 431) with videos related to
Sort By:
Pageof 44
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
Phase I study of concurrent high-dose three-dimensional conformal radiotherapy with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small-cell lung cancerIkuo Sekine, Minako Sumi, Yoshinori Ito, et al.Neuropeptides|January 18, 2016
The atypical antipsychotic, olanzapine, potentiates ghrelin-induced receptor signaling: An in vitro study with cells expressing cloned human growth hormone secretagogue receptorKeita Tagami, Yohei Kashiwase, Akinobu Yokoyama, et al.Respiratory Investigation|January 1, 2022
Correlation between body mass index and efficacy of anti-PD-1 inhibitor in patients with non-small cell lung cancerAkiko Tateishi, Hidehito Horinouchi, Tatsuya Yoshida, et al.Respiratory Investigation|September 11, 2022
Liquid biopsy for the detection of resistance mutations to ROS1 and RET inhibitors in non-small lung cancers: A case series studyYoshitaka Seki, Tatsuya Yoshida, Takashi Kohno, et al.Lung Cancer (Amsterdam, Netherlands)|February 28, 2025
Evolving treatments and prognosis in Stage IV non-small cell lung cancer: 20 years of progress of novel therapiesHironori Satoh, Yusuke Okuma, Yuki Shinno, et al.JTO Clinical and Research Reports|February 16, 2024
Distinct Progression and Efficacy of First-Line Osimertinib Treatment According to Mutation Subtypes in Metastatic NSCLC Harboring EGFR MutationsYuki Takeyasu, Tatsuya Yoshida, Ken Masuda, et al.Thoracic Cancer|March 27, 2019
Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancerNobumasa Tamura, Hidehito Horinouchi, Katsutoshi Sekine, et al.Japanese Journal of Clinical Oncology|March 28, 2019
Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II studySeiji Niho, Yukio Hosomi, Hiroaki Okamoto, et al.Journal of Cancer Research and Clinical Oncology|February 7, 2022
Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real worldSawako Kaku, Hidehito Horinouchi, Hirokazu Watanabe, et al.Journal of Gastroenterology|May 5, 2015
Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasionMasau Sekiguchi, Shigeki Sekine, Taku Sakamoto, et al.Pageof 44